Alexander Doroshenko is a Canadian infectious disease epidemiologist and public health specialist based in Edmonton, Alberta. He is an assistant professor in the Department of Medicine, Faculty of Medicine and Dentistry at the University of Alberta.[1]
COVID-19
Doroshenko is the public health representative for the AHS COVID-19 Scientific Advisory Group under Alberta Health Services (AHS).[2]
Publications
-
January 9, 2014: “Trivalent MDCK cell culture-derived influenza vaccine Optaflu® (Novartis Vaccines)”
- Co-authored with Scott Halperin, who has an extensive catalogue of vaccine-related publications and was funded by Novartis for this study
- In collaboration with the Canadian Center for Vaccinology
-
November 13, 2020: “What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model”
- Funded by Alberta Health Services and the University of Alberta
-
June 1, 2021: “The Combined Effect of Vaccination and Nonpharmaceutical Public Health Interventions—Ending the COVID-19 Pandemic”
-
September 19, 2021: “Decline of Influenza and Respiratory Viruses With COVID-19 Public Health Measures: Alberta, Canada”
- Doroshenko reported receiving personal fees from Sanofi for an advisory role.
- He also reported that his employer, the University of Alberta, was paid additional funds in research grants from the Canadian Institutes of Health Research (CIHR), Public Health Agency of Canada (PHAC), Alberta Health Services, and the University Hospital Foundation (also listed as “University of Alberta Hospital Foundation”).
- The study found that the public health measures for which Doroshenko advocated were “associated with a substantial reduction in influenza and NIRV infections in Alberta.”
-
December 2, 2021: “Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review”
- Funded by the SPOR Evidence Alliance, Canadian Institutes of Health Research (CIHR), and COVID-19 Evidence Network to Support Decision-making (COVID-END)
- Doroshenko reported receiving personal fees from Sanofi for an advisory role
- He also reported that his employer, the University of Alberta, was paid additional funds in research grants from the Canadian Institutes of Health Research (CIHR), Public Health Agency of Canada, Alberta Health Services, and the University Hospital Foundation (also listed as “University of Alberta Hospital Foundation”).
External links
Alexander Doroshenko | Public Health. University of Alberta. Retrieved January 8, 2022, from https://www.ualberta.ca/public-health/about/faculty-staff/adjunct-emeritus-faculty/doroshenko.html ↩︎
2019-nCoV Scientific Advisory Group. (2021, May 27). Alberta Health Services. https://www.albertahealthservices.ca/assets/info/ppih/if-ppih-covid-19-sag-terms-of-reference.pdf ↩︎
